HOME Top Market Reports Protein Engineering Market by Technology (Rational Design, Directed Evolution), Application (Food Industry, Environmental, Medical), Product (Instrument, Services), End User (R&D of Pharmaceutical & Biotechnology Company, Cros) – Global Forecast to 2020

Protein Engineering Market by Technology (Rational Design, Directed Evolution), Application (Food Industry, Environmental, Medical), Product (Instrument, Services), End User (R&D of Pharmaceutical & Biotechnology Company, Cros) – Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: March 2015
Report Code: UC 1207

Discount on Prebooks  

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


Humanization technique, transgenic mice technique and untapped emerging markets are offering lucrative opportunities for growth in the Protein Engineering Market

The report segments the global protein engineering market on the basis of product, application, technology, end users and geography. Based on type of product, the global protein engineering market is segmented into instruments, consumables, and software & services reagents is estimated to be the largest segment in the forecast period.

On the basis of application, the protein engineering market is segregated into antibody-based drugs, hormones, enzymes, fusion proteins, anticoagulants, blood factors, growth factors, interferons, interleukins, thrombolytics and others (bone morphogenetic proteins engineered protein scaffold among others). Antibody-based drugs segment is expected to be the fastest growing market in the forecast period. This growth is attributed to the increasing use of monoclonal antibodies in therapeutics such as oncology, auto immune and inflammatory diseases.

On the basis of technology, the segment is divided into Sequence modification/glycosylation, pegylation, display technique, humanization technique, hybrid technique, and transgenic mice. Humanization technique and Sequence Modification/Glycosylation is the largest segment of the protein engineering technology market. However, transgenic mice are the fastest growing segment by technology in the forecast period. This growth is attributed to the need for better sensitivity, specificity and faster technologies to engineer therapeutic proteins.

On the basis of end-users, the market is segmented into academic research institutes, pharmaceutical & biotechnology companies and contract research organizations. Pharmaceutical & biotechnology companies are the largest segments in the Protein engineering end user market.

North America and Europe are established markets for protein engineering. However, developing regions such as the Middle East, Asia (China and India), and Pacific countries, are expected to witness a higher growth rate. Increased intensity of research activities in the pharmaceutical sector is a major driver of these markets. To take advantage of the potential of developing economies and to gain the competitive edge, a number of companies are investing in these countries.

Table of Content

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered in the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Crackdown & Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data Points From Primary Sources
           2.3.2 Key Data Points Taken From Secondary Sources
                   2.3.2.1 Key Industry Insights
    2.4 Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increased Intensity of Research Activities in the Pharmaceutical Sector
                    5.2.1.2 Growth in Biologics Market Will Increase Research Activities Related to Protein Engineering
                    5.2.1.3 Technological Advancements to Spur the Protein Engineering Market
                    5.2.1.4 Secondary Factors
           5.2.2 Restraints
                    5.2.2.1 Need for Well-Qualified Researchers & Mandatory Training
                    5.2.2.2 Decreased R&D Expenditure in Public Sector to Restrain the Growth of the Protein  Engineering Market
                    5.2.2.3 Expensive Protein Engineering Tools and Instruments
           5.2.3 Opportunities
                    5.2.3.1 Untapped Emerging Markets
                    5.2.3.2 Partnership and Joint  Ventures
           5.2.4 Threats
                    5.2.4.1 Stringent Regulatory Framework Acts as A Major Challenge
           5.2.5 Winning Imperatives
           5.2.6 Burning Issues

6 Industry Insights
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Insights
    6.4 Porter’s Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat From Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry
    6.5 Strategic Benchmarking

7 Global Protein Engineering Market, by Technology
    7.1 Introduction
    7.2 Seq Mod/Glycosylation
    7.3 Pegylation
    7.4 Display Technology
    7.5 Humanization Technology
    7.6 Hybrid Technology
    7.7 Transgenic Mice
    7.8 Others

8 Global Protein Engineering Market, by Application
    8.1 Antibody-Based Drugs
    8.2 Hormones
    8.3 Enzymes
    8.4 Fusion Proteins
    8.5 Anticoagulants
    8.6 Blood Factors
    8.7 Growth Factors
    8.8 Interferon’s
    8.9 Interleukins
    8.10 Thrombolytic
    8.11 Others (Bone Morphogenetic Proteins Engineered Protein Scaffold)

9 Global Protein Engineering market, by Product
    9.1 Introduction
    9.2 Instruments
    9.3 Consumables and Reagents
    9.4 Software and Services

10 Protein Engineering Market, by End User
    10.1 Introduction
    10.2 Academic Research Institutes
    10.3 Pharmaceutical & Biotechnology Companies
    10.4 Contract Research Organizations

11 Geographic Analysis
     11.1 North America
             11.1.1 U.S.
             11.1.2 Canada
     11.2 Europe
     11.3 Asia
             11.3.1 Korea
             11.3.2 India
             11.3.3 China
             11.3.4 Rewst of Asia (ROA)
    11.4 Rest of the World (ROW)

12 Competitive Landscape
    12.1 Introduction
    12.2 Mergers & Acquisitions
    12.3 Agreements, Partnerships, Collaborations, Joint Ventures
    12.4 New Product Launch
    12.5 Approvals
    12.6 Expansion
    12.7 Others

13 Company Profiles
    13.1 Introducti0n
    13.2 Sanofi AG
           13.2.1 Overview
           13.2.2 Financials
           13.2.3 Products & Services
           13.2.4 Strategy
           13.2.5 Developments
    13.3 Amgen Inc.
           13.3.1 Overview
           13.3.2 Financials
           13.3.3 Products & Services
           13.3.4 Strategy
           13.3.5 Developments.
    13.4 GlaxoSmithKline PLC.
           13.4.1 Overview
           13.4.2 Financials
           13.4.3 Products & Services
           13.4.4 Strategy
           13.4.5 Developments
    13.5 Novartis AG
           13.5.1 Overview
           13.5.2 Financials
           13.5.3 Products & Services
           13.5.4 Strategy
           13.5.5 Developments
    13.6 Genentech
           13.6.1 Overview
           13.6.2 Financials
           13.6.3 Products & Services
           13.6.4 Strategy
           13.6.5 Developments
    13.7 Eli Lilly and Company
           13.7.1 Overview
           13.7.2 Financials
           13.7.3 Products & Services
           13.7.4 Strategy
           13.7.5 Developments
    13.8 Regeneron Pharmaceuticals, Inc.
           13.8.1 Overview
           13.8.2 Financial
           13.8.3 Products & Services
           13.8.4 Strategy
           13.8.5 Developments
    13.9 Novo Nordisk
           13.9.1 Overview
           13.9.2 Financials
           13.9.3 Products & Services
           13.9.4 Strategy
           13.9.5 Developments
    13.10 Biogen IDEC
           13.10.1 Overview
           13.10.2 Financial
           13.10.3 Products & Services
           13.10.4 Strategy
           13.10.5 Developments
    13.11 Affimed Therapeutics
           13.11.1 Overview
           13.11.2 Financials
           13.11.3 Products & Services
           13.11.4 Strategy
           13.11.5 Developments

*Top 10 companies in the market will be covered
#Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

Please fill in the form below to receive a free copy of the Summary of this Report



* First Name:



* Last Name:



* Job Title:



* Company:



* Email:



* Phone:



* Country:



  Do you have any Specific field of Interest?
(Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!)




Reports Interested in ::



Protein Engineering Market by Technology (Rational Design, Directed Evolution), Application (Food Industry, Environmental, Medical), Product (Instrument, Services), End User (R&D of Pharmaceutical & Biotechnology Company, Cros) – Global Forecast to 2020

* Enter the text from the image to the textbox :
5 6 0 6 8  


Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports